Biologic Drugs

May 15, 2017
Pharmaceutical Technology
A multi-pronged approach to raw materials testing can help mitigate the risk of future contamination events.
May 15, 2017
Pharmaceutical Technology
Understanding the purpose of the biological indicator can guide the development of an effective sterilization process.
May 15, 2017
By Pharmaceutical Technology Editors
Catalent has signed an agreement with Therachon to support preclinical and clinical development of TA-46, a novel protein being developed to treat achondroplasia.
May 05, 2017
By Pharmaceutical Technology Editors
Forecasts were lowered, Reuters reported, due to reduced drug approvals and increased competitive pressures.
May 05, 2017
By Pharmaceutical Technology Editors
EMA and the European Commission released a biosimilars information guide for health professionals during the EC’s biosimilars conference.
Apr 24, 2017
By Pharmaceutical Technology Editors
Sandoz has received positive opinions from EMA’s CHMP for its biosimilars rituximab and etanercept for all indications of their respective reference medicines.
Apr 24, 2017
By Pharmaceutical Technology Editors
Companies believe that biologics and biosimilars would experience the fastest growth over the next year; there is also interest on increasing market penetration of generic drugs.
Apr 18, 2017
By Pharmaceutical Technology Editors
The funding allows the company to broaden its range of services and finance its move to new laboratory facilities in the Illkirch-Graffenstaden innovation park in northeast France.
Apr 05, 2017
Sponsored Content
The ultimate goal of formulation development is a stable product. A well-designed product development plan can develop a phase 1 product quickly, while laying the foundation for commercial product success.
Apr 05, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
Researchers continue efforts to overcome challenges of effective oral delivery of biologic drugs.
native1_300x100
lorem ipsum